Tata Tech's collaboration with Telechips plans to develop innovative software solutions for next-generation software-defined vehicles ...

The development comes as the market regulator made a rare intervention to stop IPOs of at least two companies in the recent past after whistleblower complaints alleged lapses in disclosures made in th ...

While markets may remain volatile in the new year a diversified portfolio of well-researched ideas can help navigate these choppy waters ...

Anita Anand, originally from Tamil Nadu, has been one of the key figures in the Liberal Party ever since she entered politics in 2019, representing Oakville, a suburb of Toronto.

US stocks tumbled on Tuesday after a batch of upbeat economic data raised concerns that an inflation rebound could slow down the Federal Reserve's pace of monetary policy easing. The Dow Jones ...

Reliance Jio has alerted users about the premium rate service scam. Scammers place missed calls from international numbers to lure users into calling back, connecting them to premium-rate services ...

The valuation of Reliance Industries shares is the cheapest since the COVID-19 shock seen in March 2020, brokerages noted.

China maintained its tight grip on the yuan with its daily reference rate. The People’s Bank of China set the so-called fixing at 7.1887 per dollar, 1,528 pips stronger than the average estimate in a ...

Leo Dryfruits & Spices Trading shares listed on the stock market with a premium of about 31 percent over its issue price on January 8, following a subscription of 181 times to its Rs 25-crore issue.

From surge in US job openings to plans for capital raise for the AI startup-- Anthropic, here's a look at some of the major developments from across the world ...

Union Home Minister Amit Shah inaugurated the ‘Bharatpol’ portal on which aims to streamline international cooperation for law investigating agencies. Bharatpol — broadcast hub for assistance and real ...

Semaglutide and Abatacept to offset revenue losses and 80% of EBITDA impact from the Revlimid patent expiry in 2026.